# Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients

> **NCT05430269** · NA · UNKNOWN · sponsor: **Charles University, Czech Republic** · enrollment: 36 (estimated)

## Conditions studied

- Diarrhea Caused by Drug
- Clostridium Difficile Infections

## Interventions

- **OTHER:** Faecal bacteriotherapy (FBT)
- **OTHER:** standard-of-care protocolised treatment of postantibiotic diarhea

## Key facts

- **NCT ID:** NCT05430269
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-09
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2023-02-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05430269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05430269, "Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05430269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*